Miragen Therapeutics – Consensus Indicates Potential 36.8% Upside

Broker Ratings

Miragen Therapeutics found using ticker (MGEN) have now 4 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 44 and 18 and has a mean target at 31.5. With the stocks previous close at 23.03 this is indicating there is a potential upside of 36.8%. The day 50 moving average is 19.64 and the 200 day moving average is 16. The market capitalisation for the company is $90m. Visit the company website at: 0


Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp

AIM All Share Index